Tela Bio, INC Form 4 insider transactions

Gregory A. Firestone, Chief Commercial Officer of Tela Bio, Inc., reports acquiring shares and options, and disposing of shares to cover tax obligations related to vesting restricted stock units.

CEO of TELA Bio, Antony Koblish, reports acquisition and disposal of company stock and stock options.

Chief Technology Officer Paul Talmo of TELA Bio, Inc. reports acquisition and disposal of common stock and stock options.

Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports the disposal of common stock to cover withholding taxes upon vesting of restricted stock units.

Chief Accounting Officer Megan Smeykal reports acquisition and disposal of TELA Bio, Inc. common stock and restricted stock units.

Roberto Cuca, COO and CFO of Tela Bio, acquired 64,444 shares of common stock at $2.25 per share through the company's underwritten public offering.

Chief Technology Officer Paul Talmo increased his holdings in Tela Bio, Inc. by purchasing 22,222 shares at $2.25 each in a recent public offering.

TELA Bio CEO Antony Koblish purchased 88,888 shares of common stock at $2.25 per share through the company's underwritten public offering, increasing his total holdings to 458,897 shares.

Gregory A. Firestone, Chief Commercial Officer of Tela Bio, Inc., recently purchased 6,666 shares of common stock at $2.25 per share, increasing his total holdings to 57,279 shares.

Gregory A. Firestone, Chief Commercial Officer of Tela Bio, Inc., reports the disposition of 1,093 shares to cover withholding taxes and the acquisition of 1,079 shares through the employee stock purchase plan.

OrbiMed Advisors LLC, a significant shareholder of TELA Bio, Inc., has sold a portion of its holdings in a series of transactions between June 28, 2024, and July 2, 2024.

Director Douglas G. Evans of Tela Bio, Inc. reports acquiring and disposing of common stock and receiving stock options.

Director Kurt Azarbarzin reports acquiring and disposing of TELA Bio, Inc. common stock and stock options.

Director Lisa Colleran reported acquiring 4,250 shares of common stock and 6,200 stock options, while disposing of 10,520 shares of common stock.

Director Vincent J. Burgess acquired stock options and restricted stock units in TELA Bio, Inc.

Director Federica F. O'Brien reports acquiring common stock and stock options in Tela Bio, Inc.

Director Jeffrey Blizard acquired shares and options in TELA Bio, Inc. on June 4, 2024, according to a Form 4 filing.

Gregory A. Firestone, Chief Business Officer of TELA Bio, Inc., reports disposition of shares to cover tax obligations.

Tela Bio's CEO, Antony Koblish, disposed of 385 shares to cover withholding taxes upon the vesting of restricted stock units on March 31, 2024.

Chief Technology Officer Paul Talmo of TELA Bio, Inc. reports a transaction involving common stock related to tax withholding upon vesting of restricted stock units.

Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports the disposition of 96 shares of common stock to cover withholding taxes upon vesting of restricted stock units on March 31, 2024.

Peter Murphy, Chief Commercial Officer of TELA Bio, Inc., reports the withholding of shares to cover taxes upon vesting of restricted stock units.

Megan Smeykal, Chief Accounting Officer and Controller of TELA Bio, Inc., reports the disposal of shares to cover tax obligations related to vesting restricted stock units.

CEO Antony Koblish reports acquisition and disposal of Tela Bio stock and stock options.

Roberto Cuca, COO and CFO of Tela Bio, Inc., reports the acquisition of restricted stock units and stock options, as well as the disposition of shares to cover withholding taxes.

Chief Technology Officer Paul Talmo of TELA Bio, Inc. reports acquisition and disposal of company stock and stock options.

Peter C. Murphy, Chief Commercial Officer of TELA Bio, Inc., reports acquisition and disposal of company stock and stock options.

Gregory A. Firestone, Chief Business Officer of Tela Bio, Inc., reports acquisition of stock options and restricted stock units, as well as disposition of shares to cover tax obligations.